UCB SA (UCBJY)
PNK: UCBJY
· Real-Time Price · USD
92.21
0.40 (0.44%)
At close: May 01, 2025, 3:58 PM
0.44% (1D)
| Bid | 91.46 |
| Market Cap | 35.05B |
| Revenue (ttm) | 5.45B |
| Net Income (ttm) | 240M |
| EPS (ttm) | 3.12 |
| PE Ratio (ttm) | 29.55 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 92.36 |
| Volume | 684 |
| Avg. Volume (20D) | 49,883 |
| Open | 91.63 |
| Previous Close | 91.81 |
| Day's Range | 91.59 - 92.42 |
| 52-Week Range | 63.58 - 106.60 |
| Beta | 0.33 |
About UCBJY
UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkin...
Industry Biotechnology
Sector Healthcare
IPO Date Aug 3, 2012
Employees 9,052
Stock Exchange PNK
Ticker Symbol UCBJY
Website https://www.ucb.com